D
Donald A. Mahler
Researcher at Dartmouth–Hitchcock Medical Center
Publications - 97
Citations - 8714
Donald A. Mahler is an academic researcher from Dartmouth–Hitchcock Medical Center. The author has contributed to research in topics: COPD & Pulmonary rehabilitation. The author has an hindex of 37, co-authored 97 publications receiving 8085 citations.
Papers
More filters
Journal ArticleDOI
An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea
Mark B. Parshall,Richard M. Schwartzstein,Lewis Adams,Robert B. Banzett,Harold L. Manning,Jean Bourbeau,Peter M.A. Calverley,Audrey Gift,Andrew Harver,Suzanne C. Lareau,Donald A. Mahler,Paula Meek,Denis E. O'Donnell +12 more
TL;DR: There is a critical need for interdisciplinary translational research to connect Dyspnea mechanisms with clinical treatment and to validate dyspnea measures as patient-reported outcomes for clinical trials.
Journal ArticleDOI
Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines
Andrew L. Ries,Gerene Bauldoff,Brian W. Carlin,Richard Casaburi,Charles F. Emery,Donald A. Mahler,Barry J. Make,Carolyn L. Rochester,Richard ZuWallack,Carla Herrerias +9 more
TL;DR: Substantial new evidence that pulmonary rehabilitation is beneficial for patients with COPD and other chronic lung diseases and several areas of research provide opportunities for future research that can advance the field and make rehabilitative treatment available to many more eligible patients in need.
Journal Article
Dyspnea: Mechanisms, assessment, and management: A consensus statement
Paula Meek,Richard M. Schwartzstein,Lewis Adams,Murray D. Altose,Eileen Hanafin Breslin,Virginia Carrieri-Kohlman,Audrey Gift,Mary V. Hanley,Andrew Harver,Paul W. Jones,Kieran J. Killian,Ann R. Knebel,Suzanne C. Lareau,Donald A. Mahler,Denis E. O'Donnell,Bonnie Steele,Michael Stuhlbarg,Marita G. Titler +17 more
Journal ArticleDOI
Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease.
Donald A. Mahler,Patrick Wire,Donald H. Horstman,Chai-Ni Chang,Julie C. Yates,Tracy Fischer,Tushar Shah +6 more
TL;DR: It is concluded that FSC improved lung function and reduced the severity of dyspnea compared with individual components and placebo.